28 September 2020 – Roche Pays $448m to Buy Inflazome

The Big Ones

Congratulations to Mike Cavanagh at Comcast for taking up the reins of its ventures unit after Amy Banse’s decision to retire next year. Thanks goes to Banse for her support to the community over the past decade and glad she’s staying engaged through Comcast to deliver on sustainability, gender equality and mentorship.
My thanks to Ken Gatz, CEO at deal management software platform Proseeder, for running the past two days’ pitch events covering sustainability and mobility on September 22 and financial and deep technology yesterday. The GCV Connect powered by Proseeder platform reviewed the applications thanks to the expert corporate venturing judges and then showcased the finallists with the recordings edited and showreeled at the GCV Digital Forum next week, 29th.

Sweden-listed investment holding company Kinnevik’s history is one of pivots. From its initial switch from pulp and paper into telecoms and media in Sweden in the 1990s and then into online companies such as Avito, Rocket Internet and Zalando in the 2010s now comes the push into privately-held startups as it sells its $2bn stake in telecoms asset Tele2.

Exits

Roche has paid $448m to buy Inflazome, the Novartis-backed developer of treatments for chronic inflammatory conditions ranging from Alzheimer’s and Parkinson’s diseases, hepatitis B, Crohn’s disease and many others. Inflazome was spun out of University of Queensland just four years ago and also commercialises research from Trinity College Dublin. Novartis had contributed to its two only rounds that brought in a total of just over $62m.

TriNetX had raised $102m in funding from investors including Merck & Co, Mitsui and Itochu before agreeing to a purchase by Carlyle.

You may have all but forgotten about WeWork, the beleaguered co-working space provider, and in a world struggling to keep a pandemic at bay, sharing an office with strangers is hardly appealing. Yet, Trustbridge seems confident there is money to be made still and has acquired a majority stake in WeWork China for… $200m. Not only had WeWork China raised $1bn from investors including SoftBank and its Vision Fund, but was also once valued at $5bn. A source told TechCrunch layoffs had already started and “many things” remained uncertain, so we’ll see how this one pans out. In any case, it’s hardly an exit to celebrate for the investors, but they were likely prepared for that already anyway.

Even if you don’t drive an electric car, you have likely come across the term range anxiety – the fear that the battery’s charge will not last all the way to the driver’s destination. It is often considered a significant barrier to large-scale adoption of EVs, so seeing ChargePoint – which operates an international charging network – agreeing to a reverse merger with SPAC Switchback Energy Acquisition can only be good news. The deal values ChargePoint at $2.4bn and will, once it closes in Q4, net the business $683m in fresh funding. That’s a smidgeon more than the $667m it had raised in equity financing from backers such as AEP, BMW, Chevron, Constellation Energy, Daimler, Siemens, The Hartford and Toyota.

Speaking of the transportation sector: Ninebot – best known for the Segway brand – is looking to go public in China through a $295m IPO on Shanghai’s Star Market. The Xiaomi and Intel-backed company’s move is intriguing not so much for the IPO’s target size (though that is notable, too) but because it’s the first company with a variable interest entities (VIE) structure that’s been approved to list using Chinese Depository Receipts. VIE is a framework that enables foreign investment in companies that are restricted from accepting overseas capital due to their sensitive nature. Typically, the structure is employed by China-based companies undertaking a listing elsewhere and up until now Beijing made companies unwind this structure if they sought to list at home – but rising tensions with the US have seemingly provoked some flexibility from the central government.

Tencent-backed low-cost retailer has put a $100m placeholder figure in its filing for an IPO on the New York Stock Exchange, more than a year after its plans first emerged.

Compass Pathways, a UK-based depression medicine developer backed by pharmaceutical group Otsuka Pharmaceuticals’ McQuade Center for Strategic Research and Development, achieved a different kind of exit as it went public in an upsized IPO worth more than $127m on Friday. The company is working on something rather unusual: a synthetic version of psilocybin, the psychedelic compound in magic mushrooms, to treat mental health disorders that have proven resistant to other therapies. McQuade had backed an $80m series B round in April 2020 and its bet paid off, as shares in Compass shot up to $29 on the first day of trading.

If you were looking forward to whatever blockbuster terms Grail was going to set for its IPO when it first filed with a $100m placeholder amount earlier this month, you’ll be sorely disappointed with today’s news. However, the $8bn put down by Illumina (though when accounting for its existing stake it’s closer to $7bn) to acquire its cancer diagnostics spinoff is impressive in its own right – particularly considering that Grail raised just under $2bn, so Illumina could have saved a decent chunk of cash if it had kept the development internal – but that’s the nature of these things. WuXi AppTec, Tencent, Amazon, Alphabet, Varian Medical Systems, BMS, Celgene, Merck & Co, Memorial Sloan Kettering Cancer Center, Johnson & Johnson and McKesson are all among the corporates celebrating an exit.

Speaking of China: Zhonggu Logistics, a container logistics services provider backed by liner operator Zhonggu Shipping and telecommunications group SoftBank, is targeting a $218m initial public offering after pricing its shares at $3.28 a pop. It will list on the main board of the Shanghai Stock Exchange, and Zhonggu Shipping will remain a majority shareholder at 63.1%, with a tiny slice (2.2%) also left for SoftBank. CICC is the lead underwriter.

The Washington State University neurological drug developer has gone public after issuing 12 million shares priced at $17 each.

Deals

News continues coming in at a rapid pace, proving that the summer lull – however much there was one, considering the flurry of IPO filings as discussed earlier – is well and truly over. If you live in the west, you’d be forgiven for thinking Tesla is the only real contender in the EV space but there are other noteworthy companies in the east. One of these is WM Motor, which has picked up $1.47bn in a series D round backed by SAIC Motor – adding to some $1.8bn in funding previously raised from investors such as Baidu, Tencent and China Minmetals. The money has been allocated to R&D, marketing, sales and branding activities.

There really is no stopping Robinhood, the US-based share trading app developer backed by Alphabet and Roc Nation: the company has now pushed its series G round to $660m thanks to a $460m extension supplied by D1 Capital Partners (which had provided the $200m initial tranche last month), a16z, Sequoia, DST, Ribbit and 9Yards. The extension has moved Robinhood’s valuation up to $11.7bn from $11.2bn a few weeks ago – that seems like a marginal increase hardly worth mentioning but in July the company was actually worth “only” $8.2bn when it closed its $600m series F. It’s now collected some $2.36bn in funding altogether.

Challenger bank Chime has become the most valuable American fintech aimed at retail consumers after raising $485m in a series F round that pushed its valuation to $14.5bn – a good chunk of change more than previous leader Robinhood, which attained an $11.2bn valuation last month. If $14.5bn seems a lot – and it is – consider this: Chime claims it has been adding hundreds of thousands of customers per month as the pandemic has made people less inclined to go into a physical bank branch. Consider this, too: the company was worth a mere $1.5bn just 18 months ago. Access Industries returned for the latest round but Chime’s early investors, which include Northwestern Mutual Future Ventures, will also all be in for a phenomenal exit at this rate.

Munich Re has returned for a $250m series D round raised by online insurance platform Next Insurance, while CapitalG led the round. Next Insurance has grown to more than 100,000 customers across all 50 US states and will use the money to improve its existing offering, add more products and hire an additional 200 employees. Next has now raised $631m in total – Munich Re previously injected $250m in series C financing a year ago – and its investors also include Nationwide (the US insurer, not the UK financial institution), Markel and American Express Ventures.

Apple’s silicon in iPhones and iPads is notably because the chips manage to squeeze an astounding amount of processing power out of small real estate at low power usage. The team that led the development of these chips left last year to found Nuvia in an effort to bring their expertise to semiconductors in data centres. While its technology is still very much in development, it clearly has done enough to entice investors for a $240m series B round that featured returning backer Dell Technologies Capital.

Children’s debit card provider Greenlight is valued at $1.2bn after raising $215m in a funding from a host of investors, though none of its corporate backers participated this time.

Xingyun has picked up $200m in a series C round co-led by Taikang Insurance, Shanghai United Media Group and Highlight Capital, while GLP and C&D Group also invested.

There was a $133m series C round secured by Beyond Limits, an AI technology developer based on research at Caltech’s Nasa-aligned Jet Propulsion Lab that is notable not only because it’s repeatedly convinced BP Ventures to invest but also because it actually managed to attract BP Ventures’ Meghan Sharp as COO about a year ago (as long-time subscribers will remember). Another corporate, Group 42, joined BP for the series C round.

SoftBank’s Latin America Fund and General Atlantic have co-led a $107m series B round for Accesso Digital, a facial recognition technology developer that will use the money to scale.

Digital Garage has helped launch mobile gaming platform Playco with a $100m series A round and a valuation of more than $1bn.

Recycling electronics is big business – rare earth minerals needed to build devices such as laptops or smartphones are expensive to mine, but old gadgets too often just end up in that junk drawer we all have in our houses. This is where Wanwu Xinsheng – né Aihuishou – comes in: it runs an online and brick-and-mortar recycling service for consumers to sell their second-hand devices. The company’s now raised $100m in series E-plus financing from JD.com, its JD Logistics unit and others, to accelerate growth and seek additional partnerships internationally. The round brings the company’s overall funding to more than $1bn, and JD.com is a repeat investor.

Another nine-figure sum was revealed by Nucarf, a China-based logistics fleet refuelling management platform that has collected $100m in combined series A and A-plus capitalfrom investors including Xiamen C&D. The cash has been allocated to accelerating the development of its digital infrastructure, and it comes after multiple rounds of undisclosed size in 2017 and 2018.

Foot Locker-backed sneaker marketplace Goat Group has completed a $100m round from D1 Capital Partners, bringing its overall financing to almost $300m in five years.

University

UW mental health spinout Owl Insights secured funding to advance its product development and distribution.

Funds

The website development tool provider’s Wix Capital subsidiary will invest in early-stage startups that are developing AI, e-commerce, web design and automation technologies.

Pureos Bioventures has backed five spinouts so far from its inaugural biotech-focused fund, which has reached its final close.

Unnamed corporates have provided capital for Panlin’s $148m fund that will focus on healthcare, digital transformation and smart hardware.

Legal & General is among the limited partners for Kindred Capital’s second fund, which also attracted University of Chicago and will invest in early-stage European startups.

Alsa Ventures is targeting a $150m final close for its inaugural biotherapeutics fund, which has already backed university-linked companies.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

24 August 2020 – SpaceX Raises $1.9bn

The Big Ones

SpaceX has been one of the most fervent fundraisers among private companies in recent years and it shows no signs of stopping. A securities filing indicates the spacecraft manufacturer and launch services provider has secured $1.9bn from undisclosed investors, with recent media reports putting the valuation of the round at $46bn. Its earlier backers include Google, which invested $900m at a $12bn valuation five years ago, and that valuation looks set to keep on rising for now.

Consumer electronics manufacturer Konka Group has teamed up with the Chinese city of Yancheng to put together an industry fund that will begin investing from a base of about $435m. The fund will be sized at up to $1.45bn and Konka is providing 40% of the capital. Its areas of interest include AI, semiconductors, the internet-of-things, new machinery and advanced materials.

Airbnb has announced it has confidentially filed for its long-awaited initial public offering. People were talking about an Airbnb flotation before the last downturn in the IPO markets in 2018. The rebound last year wasn’t enough to tempt it, but now, while they’re rallying for tech stocks, seems to be the right time despite a coronavirus-related hit to Airbnb’s business that saw it lay off 25% of its staff in May. The CapitalG-backed company had been valued at $26bn, down from $31bn, when it raised $1bn in debt and equity the previous month.

We have finally hit that summer lull on GUV, but there were still a few big stories. Most notably, Mission Bio, a US-based DNA analysis technology spinout of University of California, San Francisco (UCSF), has raised $70m in a series C round led by pharmaceutical firm Novo’s Novo Growth unit. Agilent Ventures, the corporate venturing arm of laboratory equipment and diagnostics services provider Agilent Technologies, also took part in the round, as did Cota Capital, Mayfield Fund and Soleus Capital. The round took the company’s total funding to more than $120m, it said, and Robert Ghenchev, head of Novo Growth, has joined its board of directors. Founded in 2014, Mission Bio has created a system called Tapestri which enables researchers and medical professionals to analyse single-cell RNA sequencing data to help develop precision medicines. The spinout leverages genomics technology from UCSF’s Abate Lab.

Deals

E-commerce group JD.com”s pharmaceutical product and medical services spinoff JD Health raised $1bn at a $6.9bn valuation last year, and now it’s agreed to add series B funding from investment manager Hillhouse Capital. The deal is set to be finalised next month and JD Health expects to get upwards of $830m from Hillhouse, an investor in its parent company since its 2012 series C round.

Last week we talked about reports that Chinese online medical insurance and crowdfunding service Waterdrop had raised $200m at a $2bn valuation, but a subsequent announcement places the size of the round at $230m. Tencent and Swiss Re co-led the round, which sources told Reuters valued Waterdrop just short of $2bn. Swiss Re has been relatively quiet in the corporate venturing space in recent years but reportedly put up $100m of the capital in this round.

Online share trading has made a big jump as the stock markets rally, and RobinHood is getting a lot of business in the US market. It has accordingly increased its valuation from $8.3bn to $11.2bn in the space of just four weeks, its latest move being to raise $200m in series G financing from investment firm D1 Capital Partners. It has now secured a total of $1.7bn and its earlier investors include Roc Nation’s Arrive subsidiary as well as Alphabet units GV and CapitalG.

Palfish is one of several Chinese online education providers to have experienced growth during Covid-19 lockdowns, and it has raised $120m in a series C round that included quantitative trading firm Susquehanna International Group. The company specialises in English tutoring and claims to have some 40 million users. It will put the funding towards improving its big data technology.

BlockFi has been one of the more frequent fundraisers in the startup space having closed five rounds in just over two years as it expands its range of digital currency services. The latest is a $50m series C round that included subsidiaries of CM Group and Siam Commercial Bank. The company has now secured more than $160m and its earlier backers include Consensys, SIG, Recruit and SoFi.

There are several VC-backed companies operating under the moniker of Element but the latest to raise money is the Germany-based bespoke insurance software provider, which has added funding from investors including Sony Financial Ventures and SBI Investment to a series A round that now stands at $46.5m. The earlier tranches featured Signal Iduna and Mitsui Sumitomo Insurance.

Funds

MDI Ventures, the corporate venturing arm of Indonesian state-owned telecommunications firm Telkom, has closed a $500m fund entirely financed by the company. It will invest between $5m and $30m in domestic digital technology developers that will get access to a range of government-owned corporations, which in turn will be able to leverage the technology required to form a digital ecosystem in the country.

Russian conglomerate Sistema may not be the most active participant in the corporate venturing space but it does have one of the largest ranges of investment, having closed a series of funds focusing on different regions and sectors. Its Sistema Asia Capital subsidiary closed a $120m India fund in 2015 and is in the midst of raising the same amount for a vehicle concentrating on Southeast Asia. Areas of interest include cybersecurity, computer vision, smart cities, urban mobility and the internet-of-things.

Exits

Pharmaceutical companies Juno Therapeutics (itself a spinout of Fred Hutchinson Cancer Research Centre, Seattle Children’s Research Institute and Memorial Sloan-Kettering Cancer Centre) and WuXi AppTec founded cancer immunotherapy developer JW Therapeutics in 2016 and now it has filed for an initial public offering in Hong Kong. Recent reports suggested JW would target $250m to $300m in the IPO having already raised more than $200m in venture funding. Juno retains a 26% stake in the company while WuXi AppTec owns about 14% of its shares.

Biologic drug developer Inhibrx has gone public, raising $119m having floated at the midpoint of its range. Inhibrx had received some $135m in equity and debt financing from investors including Eli Lilly and WuXi Biologics, and its share price followed recent trends by rising post-IPO. It’s been a bumper time for newly public companies of late, the question is how much of a bubble this represents and whether latecomers to the party could end up missing out.

Nano-X Imaging is working on a medical imaging system intended to function as a more affordable alternative to X-ray machines, and the Israeli company has set terms for an initial public offering in the US that will raise almost $106m if it floats at the top of its range. A big impetus is that existing investors including corporates Foxconn, SK Telecom and iA Financial have expressed interest in buying up to $80m of shares in the offering, which is a more than decent vote of confidence.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

20 July 2020 – 5G & IoT Provider Jio Platforms Gains $4.5bn from Google

The Big Ones

Jio Platforms was spun off by Indian conglomerate Reliance Industries late last year to build a mobile network tailored for 5G and the internet of things, and everyone seems to want a slice. The latest is Google, which is paying $4.5bn for a 7.7% stake in Jio, the deal coming in the wake of parent company Alphabet’s recent pledge to invest some $10bn in India over the coming years. Qualcomm Ventures and Intel Capital had supplied a total of $350m for it earlier this month – Qualcomm’s actually came only a few days before Google’s investment. Meanwhile Facebook paid $5.7bn for a 10% stake in April.

Alphabet announced that it intends to channel up to $10bn into India through a newly formed vehicle dubbed Google for India Digitization Fund. That commitment will include equity funding for domestic companies, though as yet it’s unclear whether that will be deployed through the corporate’s investment subsidiaries. One of them, CapitalG, has already invested in several Indian companies but GV is yet to establish a presence in the region.

There’s been more IPO action this past week, beginning with electric vehicle battery producer Farasis Energy, which raised approximately $486m in an offering on the Shanghai Stock Exchange’s Star Market. It raised a reported $193m from investors including strategic partner Daimler earlier this month, and the corporate venturing arm of another carmaker, BAIC, is also among its shareholders.

On GUV, Paige, a US-based cancer pathology software spinout of Memorial Sloan Kettering Cancer Center, extended its series B round to $70m with commitments from Goldman Sachs Merchant Banking Division and Healthcare Venture Partners. Both were returning investors from previous tranches. The initial series B close last year had also featured Brey Capital, private investor Kenan Turnacioglu and undisclosed funds. Leo Grady, chief executive of Paige, told GUV: “The past year has underscored the need for pathology to adopt a digital workflow. As hospitals and labs look for solutions, they are seeing Paige as uniquely positioned: providing an enterprise solution for digital pathology images across sites and scanners while leveraging advanced cancer detection and characterisation solutions to provide additional information to the pathologist during diagnosis.”

Deals

RobinHood has seen demand for its share trading platform skyrocket during the Covid-19 lockdown, so much so it’s delayed the app’s UK launch. It has added 3 million new accounts and has followed that by adding $320m to a series F round that now stands at $600m. The company, which is backed by Alphabet unit CapitalG and Roc Nation, secured the capital at an $8.3bn valuation and has now raised a total of nearly $1.5bn in venture funding.

UiPath, a developer of robotic process automation technology that facilitates the automation of repetitive tasks like data entry, can also be said to be a company with a lockdown-relevant product. It has pulled in $225m through a series E round featuring Tencent that boosted its valuation from $7bn in May 2019 to $10.2bn post-money. CapitalG is also among UiPath’s investors, having first backed it in a 2018 series B round.

In Japan, ride hailing platform Mobility Technologies (MoT) has agreed up to $211m in corporate funding, with the lion’s share to come from mobile network operator NTT Docomo. The round included Dentsu and Tokyo Century and it shows the benefits of pivoting when the time is right. MoT began life as a taximeter software producer but has raised money from investors also including Toyota and Kakao Mobility since it switched tack.

Another Salesforce-backed company, Auth0, is also valued at $1.9bn, following a $120m series F round led by corporate VC vehicle Salesforce Ventures. Telstra Ventures also took part in the round, as did Deutsche Telekom’s DTCP unit, and the user authentication software provider intends to leverage Deutsche Telekom’s resources as it expands internationally. It has now secured more than $330m altogether.

Qumulo, developer of a cloud-based data management system, has completed a $125m series E round led by BlackRock that took its total funding above $350m. The cash was secured at a valuation of more than $1.2bn and it comes roughly two years after a series D round featuring disk drive manufacturer Western Digital. The cash will support product development and international growth.

Funds

We already had one huge fund but there was another last week: 23 biopharmaceutical companies have provided a total of almost $1bn in capital for AMR Action Fund, a vehicle tasked with helping to combat antimicrobial resistance by investing in companies developing new antibiotics. Those backers include Pfizer, Merck & Co and Johnson & Johnson, which are each supplying $100m. AMR Action Fund is slated to begin operations in the fourth quarter of 2020.

Exits

Small molecule cancer drug developer Relay Therapeutics has bagged $400m from its initial public offering, increasing the number of shares by more than a third and floating above its range. Its shaves have also risen post-IPO, providing a success story that’s badly needed for its largest investor, SoftBank Vision Fund. Although Vision Fund’s consumer-facing investments have been somewhat patchy, its life sciences deals seem to be paying off.

Banking software provider nCino has raised $250m in a flotation that saw it float a full $7 above its range. Its shares then nearly tripled in their first day of trading yesterday to give it a valuation of more than $1.9bn. The IPO is also a success for Salesforce, which owns a 12% stake having invested $72m in nCino between 2016 and late last year.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

11 May 2020 – Intel picks up Moovit for $900m

Big Stories

Korys, the family office behind the France and Belgium-based retailer Colruyt Group, and Mérieux Equity Partners, the asset management arm of the Institut Mérieux holding company, have set up joint funds targeting companies in the healthcare and nutrition sectors in Europe and North America.

OMX Europe Venture Fund has raised more than €60m from Korys and Mérieux and third party subscribers and is targeting a final close at €90m. OMX Europe will be managed by Mérieux Equity Partners in Europe, with the operational support of Korys’ Life Science team as a key advisor to the fund.

The value of Intel’s acquisition of Israel-based urban mobility app developer Moovit for a $900m enterprise value lies almost as much as what it says about the ecosystem developed there over the past 30 years since Russian immigration after the fall of the Soviet Union.

Israel had always battled its neighbours and developed a strong military but the influx of people needing jobs helped catalyse a startup ecosystem and funding of venture capitalists to enable it.

The integration of corporate research and development and venturing units has catalysed this trend even further over the past decade, as identified in the latest GCV Israelconference in February.

We have seen some big deals so far this year in the financial services sector, with Visa acquiring Plaid and Mastercard joining AvidXchange, but while payments remains localised in many cases the opportunities to join up the global commerce world beckons.

Hence the after-market performance of Australia-listed Afterpay, which surged following China-based Tencent’s acquisition of a 5% stake. Alibaba had its purchase of Western Union’s spinout MoneyGram turned down by US authorities but is also trying to become the global payments provider of choice given Chinese blocks on Visa and Mastercard’s expansion in the world’s second-largest economy.

We live in a world of seemingly the very large and the very small.
An exabyte of data is the equivalent of a stack of DVDs about 255.3 kilometres high. Each transistor in a state-of-the-art chip measures only 5 nanometres (nm) — the length a human fingernail grows in five seconds.
The world increasingly turns around data and processing power and if data is the new oil the 21st century wars could see as many wars fought over control of the ones and zeros as were fought over black gold in the last century. In which case Taiwan becomes an important centre to watch.
In last month’s Global China, Saif Khan and Carrick Flynn argued for maintaining China’s dependence on democracies for advanced computer chips through export controls. These democracies, particularly Taiwan, the US and South Korea, lead the development of the most advanced chips – those with transistors of between 5nm and 16nm.

Japan has struggled to keep up and so it was little surprise in the past week to seeDealStreetAsia report Japanese venture capital firm Jafco has made the final close of its debut Taiwan venture fund at NT$2bn ($67.1m) with limited partners including the National Development Fund of Taiwan.

Funds

Kurma sets the stage for $175m fund

Some areas may not be an obvious choice for investment in the time of lockdown but it seems the automotive sector is well and truly alive with Autotech Ventures announcing that it has closed its second fund at more than $150mthanks to a long list of corporate LPs – though only Lear, Stoneridge, Bridgestone and Volvo were identified. The firm now has more than $270m under management and will, apart from the obvious areas of connectivity, automation and electrification, also explore more niche investments, such as junkyard inventory management technologies.

University

Shift hits play on $70m fund

Fitz Gate seals second Princeton-focused fund

Edinburgh sparks food science incubator

Deals

It is easy enough to forget, with the world’s focus on coronavirus, that other diseases are costing countless more human lives. Chief among these is cancer, some forms of which have become easier to treat but prognoses are still significantly better the earlier the disease is caught. Illumina spun out Grail four years ago to make that early detection a reality through a blood test that can not only detect the presence of more than 50 different cancer indications but can also tell the oncologist where in the body the cancerous tissue is – all while boasting an almost negligible false positive rate of less than 1%. But developing such a test costs a lot of money, so it is heartening to see that Illumina and others have doubled down on the company and backed a $390m series D round that brought Grail’s total funding to some $2bn.

Another company that has done well out of people asked to stay at home is Byju’s, the online education provider backed by Prosus and Tencent, which is looking to add $400m to an ongoing funding round that reportedly already stands at $300m to $350m. Better news for the company still: it is set to push its valuation from $8bn just three months ago to more than $10bn. That seems fast, and it is, but consider that Byju’s added six million users in March alone and India’s lockdown was only implemented in the last week of that month.

Octopus Energy, a British renewable energy supplier that has steadily grown to more than 1.3 million customers since it was launched five years ago, has attracted its first external funding thanks to a $327m commitment from Origin Energy in return for a 20% stake. Origin made the investment specifically to secure a licence for Kraken, Octopus’ cloud-based software platform to interact with customers and enable functionality such as wholesale market trading and consumption forecasting. With Australia increasingly feeling the impact of global warming (even if the catastrophic fires earlier this year already seem like a distant memory), partnering with a green energy supplier is a welcome move.

Another sector that is doing well out of reduced human contact are financial services providers and N26 has wasted no time in adding $100m to a series D round that now stands at $570m. Notably, the additional capital was raised at a flat valuation of $3.5bn. That may not be too unusual for a third tranche, but the company had managed to increase its valuation by $800m between the first and second tranche, backed by Tencent and Allianz X. Consider, however, that N26 actually pulled out of market between the first and second extension, as the UK’s exit from the European Union just caused too much of a headache for the digital bank that relies on an EU-wide banking licence for its business.

Robinhood captures $280m series F

SoftBank and its Vision Fund may have been in the news for all the wrong reasons lately, but that doesn’t mean there is no support left for portfolio companies. Indeed, new and used car trading platform operator Chehaoduo has secured an additional $200m from the Vision Fund and Sequoia Capital to add to a $1.5bn initial series D tranche – supplied in full by the corporate – in February last year. It may not be an obvious candidate to raise money in the current climate, but with trouble brewing elsewhere in the fund’s portfolio, an automotive marketplace and after-sales services provider seems like a decent bet.

SoftBank also hasn’t had the best experience dealing with Mexico’s regulator the Federal Economic Competition Commission (Cofece), having been sanctioned recently because it failed to notify Cofece that it had acquired a larger stake in WeWork. You can understand then that the corporate treaded a bit more carefully with its lead investment in US-based digital lending platform AlphaCredit’s $125m series B round through the Vision Fund. AlphaCredit, which targets customers in Mexico and Colombia, had initially announced the deal in January, but it took until last week for Cofece to give the all-clear. That timing is good news not just for SoftBank and AlphaCredit, but also for the consumers and SMEs that are in desperate need of loans right now to weather the crisis.

Ninja Van picks up $279m in funding

Asapp accesses $185m series B

Flint Hills Resources, the chemicals and biofuel subsidiary of conglomerate Koch Industries, is not a corporate backer we come across often on GCV – in fact, it has seemingly only taken part in half a dozen deals since 2010 – but as the world battles an ever-increasing mountain of plastic polluting the environment, the need for a commercial-scale biodegradable alternative is becoming imperative. Enter RWDC Industries, which is working on just such a material and has secured $133m in a series B round backed by Flint Hills Resources to scale up its US operations by repurposing an idle factory in Athens, Georgia.

Back Market certifies $120m round

ASR processes $119m round

Praxis Precision was co-founded four years ago by faculty from Columbia University and University of Melbourne, but the gene therapy developer – targeting neurological and psychiatric disorders – remained quiet about its business until now, emerging from stealth with more than $100m in funding raised to date from investors including Novo Holdings. All of that money has clearly been put to good use: Praxis already has two assets in phase 2 clinical development, one for major depressive disorder and one for essential tremor.

Enflame lights up $98.7m series B

Exits

Kingsoft Cloud to claim IPO throne

University

Abiomed absorbs Breethe


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

20 April 2020 – Stripe Raises $600m in Series G Plus Audio from our Industrial Sector Webinar

The Big Ones

Digital payment processor Stripe is one of the companies that has seen demand for its product skyrocket in recent weeks as more and more commerce moves online. It has also raised another $600m from investors including GV to meet that demand, taking a series G round valuing it at $35bn pre-money to $850m. The company’s earlier backers include Visa and American Express- both of which invested at a $5bn valuation – and Sumitomo Mitsui Card Company.

There’s been no respite for SoftBank over Easter, as the telecoms giant revealed in its annual report that it expected to book a $16.8bn loss on investments from its Vision Fund in the fiscal year that just closed. That figure, which encompasses a huge loss in value for WeWork along with the disintegration of investments in the likes of OneWeb and Brandless, is staggering, and SoftBank has reportedly frozen its second Vision Fund, which was in the fundraising stage. But with most of its consumer-facing portfolio facing trouble right now, what will happen to that portfolio if those companies find their largest investor has suddenly closed their wallet?

Zomato acquired Uber Eats in a $350m all-share deal in January and now the restaurant listings and food delivery platform is reportedly in talks to buy online grocery delivery service Grofers in a similar deal that will value the latter at $750m. The transaction could hypothetically be sweetened by an investment of $100m to $200m from Grofers’ largest shareholder, SoftBank Vision Fund, though it’s unclear whether that will still stand in light of news SoftBank is freezing its second Vision Fund.

Identity verification seems to be a hot sector all of a sudden (we’ll have more in a minute for you). Onfido, which emerged out of the software incubator of University of Oxford’s tech transfer office Oxford University Innovation eight years ago, has raised $100m. The round featured M12 and Salesforce Ventures, as well as unnamed backers, and was led by TPG Growth. Onfido allows companies to biometrically verify a user’s identity by algorithmically comparing a picture of an ID document, such as a passport, with a selfie. It’s used by more than 1,500 organisations, such as digital bank Revolut. Its early backers include the Seed Fund of Oxford’s Saïd Business School Entrepreneurship Centre.

Deals

Despite suffering several outages in early March, share trading app developer Robinhood has emerged as one of the tech-based companies that have seen demand for their product intensify during the Covid-19 pandemic. Now, the company, whose backers include Alphabet units CapitalG and GV as well as Roc Nation’s Arrive vehicle, is reportedly closing in on $250m in funding. The round looks set to be led by existing backer Sequoia Capital, and to lift Robinhood’s valuation from $7.6bn to $8bn pre-money.

Elsewhere in the fintech world, cross-border remittance service Airwallex has closed a $160m series D round that included Tencent and corporate venturing units Salesforce Ventures and Anzi Ventures at a reported $1.8bn valuation. Airwallex is one of that rare breed of successful Australian startups that have elected to remain in their home country instead of moving to Silicon Valley, and it’s a useful example that you don’t necessarily have to move where the most action is in order to reach those high valuations.

China-based drug developer MabWorks has collected $160m in a two-tranche series C round featuring an investment vehicle for industrial park operator Beijing E-Town Biomedical Park. MabWorks has some 15 assets in clinical trials in China or the US, many of which are targeted at cancer, and is focusing on a monoclonal antibody approach.

As promised, more identity verification for you with BioBatch, which has netted $145m in a series C featuring CreditEase and American Express Ventures. Both corporates took part in BioBatch’s last round – a $30m series B two years ago – and that jump suggests demand for its behavioral biometrics technology has grown sharply during that time.

Consumer finance platform Paidy has raised another $48m from trading group and existing backer Itochu that it added on to the $143m in series D funding it closed in November, bringing the round to $191m. Itochu had contributed to that close, as did fellow corporate investors Visa and PayPal Ventures, and it has now committed a total of $91m to Paidy, which has received $281m in debt and equity financing to date.

Ninja Van has racked up $124m in series D funding over the past year, according to data sourced from DealStreetAsia. Corporates GeoPost, Grab, Carmenta and Intouch Holdings provided a total of $50m while GeoPost has supplied a further $79m in convertible note financing since September 2018. The series D reportedly valued the Southeast Asian last-mile delivery service at about $590m.

Cloud kitchen operator Rebel Foods also operates in India’s food delivery sector and has raised $50m from hedge fund manager Coatue Management. Rebel counts Gojek, Sistema and Northwest Industrial Logistics as early investors but while the Coatue deal may seem an endorsement, it’s worth noting that reports in February suggested it was going to come as part of a round sized at up to $150m, at a $1bn valuation. This is a space that could definitely see some more consolidation in the coming months.

Cerevance, a spinout of Rockefeller University, has created technology that helps it assess post-mortem brain tissue in order to develop treatments for brain diseases like Alzheimer’s. It has also secured $45m in a series B round that included corporate VC units GV and Takeda Ventures. The latter had already taken part in Cerevance’s 2016 series A round but its contribution to this one came in the wake of a December 2019 research agreement between Cerevance and its parent company, pharmaceutical firm Takeda.

Funds

China-based, Southeast Asia-focused venture capital firm ATM Capital has closed a fund backed by corporates Alibaba and 58.com at about $100m, DealStreetAsia reported citing sources privy to the development. Founded in 2017, ATM Capital aims to bring Chinese expertise to bare helping Southeast Asia-based startups grow. The fund is its first and it had set a $200m target for its final close, but sources told DealStreetAsia the Covid-19 crisis had impacted fundraising activities.

Corigin Ventures, the venture capital firm sponsored by US-based real estate developer Corigin, has closed its second fund at approximately $36m. The firm targets consumer and property technology developers in the US and Canada. It invests $100,000 at pre-seed stage and provides between $500,000 and $1.25m for seed-stage deals, with additional capital reserved for follow-on investments. Corigin Ventures began raising the capital in mid-2018 and the fund had a $50m target according to securities filings. It is the first to include contributions from external limited partners, according to TechCrunch.

China-based early-stage venture firm Qiming Venture Partners has closed its seventh fund at $1.1bn with investors including Princeton University Investment Company, the manager of the institution’s $26bn endowment. The fund’s other limited partners include unnamed endowments, foundations, family offices and private pensions. Princeton’s been an investor in Qiming funds since its very first US dollar-denominated vehicle.

Exits

Verizon has agreed to acquire video conferencing software provider BlueJeans for a price reported to be below (but reportedly not that far below) $500m, in a deal that will allow Deutsche Telekom’s DTCP subsidiary to exit. BlueJeans had raised about $175m, its most recent funding coming in a 2015 series E round.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

04 November 2019 – Greensill Raises $655m from SoftBank

The Big Ones

Greensill, a UK-based company that taps the capital markets in order to provide working capital for businesses, received one of this year’s biggest investments in May when it secured $800m from SoftBank Vision Fund. Now it’s added a further $655m from the same investor at a valuation reportedly nearing $4bn.

Singapore-based venture capital firm Jungle Ventures has closed its latest fund at $240m, securing the capital from LPs including, according to DealStreetAsia, Cisco Investments and Bualuang Ventures, the corporate venture capital arm of Bangkok Bank, as well as Temasek, the World Bank’s International Finance Corporation, development finance institutions DEG and FMO, and Kuok Khoon Hong, chief executive of agribusiness Wilmar International.

Wag raised $300m from SoftBank Vision last year but the petsitting service has been among the vehicle’s less successful bets, after a series of management changes, layoffs and (perhaps we need a trigger warning here) reports that users’ dogs have died while in the custody of its walkers. The company is now pursuing a sale and is in talks with Petco, though things might be complicated by the fact the latter is an investor in Wag rival Rover. Any sale is also likely to be for less than the $650m valuation at which Vision Fund invested.

Finally, in a nice crossover story (and ongoing one, since several of the corporates were returning investors) we have Tmunity Therapeutic, a developer of T-cell immunotherapy treatments for cancer and autoimmune diseases, has boosted its overall funding to $231m with a $75m series B round featuring Gilead Sciences and Be The Match BioTherapies as well as University of Pennsylvania, of which Tmunity is a spinout.

Deals

Trading app developer RobinHood has added $50m to a series E round that now stands at $373m, and which values it at $7.6bn. The extra cash came from existing investor DST Global and it increased the total raised by RobinHood, which also counts Roc Nation’s Arrive unit and Alphabet subsidiaries CapitalG and GV among its past investors, to more than $910m.

Vacasa has notched up its own nine-figure round, raising $319m from investors led by Silver Lake. It operates a peer-to-peer holiday accommodation booking platform that incorporates property management services, allowing owners of properties where they are often not present to garner extra income with minimal effort.

Mobile game publisher Scopely is on the growth trail and plans to follow up its acquisition of collaborator Digit Games earlier this year with additional M&A deals. They will be financed with $200m of series D funding the company just raised at a reported $1.7bn valuation, with NewView Capital leading the round.

Japanese online consumer credit provider Paidy has raised $143m in debt and equity financing that included an $83m extension to its series C round. That extension included PayPal Ventures and followed on from a $55m first tranche featuring corporates Itochu and Visa.

And after-sales automotive services provider CassTime has secured $80m in a series C1 round co-led by Sequoia Capital China and Source Code Capital that boosted its overall funding to some $175m.

Pollinate has officially launched its digital banking technology offering having secured $77.8m in funding from investors including Mastercard and Royal Bank of Scotland (RBS) as well as Motive Partners and EFM Asset Management.

Funds

Qualcomm Ventures has announced an investment vehicle called the 5G Ecosystem Fund which will fund developers of 5G technologies as parent company Qualcomm looks to move more significantly into the area. The unit will look to invest up to $200m through the vehicle, the launch of which follows the formation of a $100m AI Fund almost a year ago.

Exits

Phathom Pharmaceuticals has gone public, securing nearly $182m in an initial public offering in which the gastrointestinal disease therapy developer floated in the middle of its range. Phathom has licensed its core product from pharmaceutical firm Takeda, which has already successfully marketed the drug in its home country of Japan, and which has seen its stake rise from 9.1% to 24.7% in connection with the IPO as part of the licensing agreement.

Fertility benefits management platform Progyny has also floated, in a $130m offering in which Merck Group sold almost $4.9m of shares. That divestment was made as part of nearly $43m of sales from existing shareholders, while Progyny reaped more than $87m. Its other investors include GlaxoSmithKline’s corporate venturing unit, SR One.

Xiaomi-backed podcasting platform Lizhi has filed for an initial public offering in the US and is targeting $100m. Lizhi is yet to finalise its choice of a market for its listing (it’s a choice between NYSE and Nasdaq Global Market) and it’s going to be interesting to see the timeline of the proposed offering, considering the IPO market is slowing down and relations between its home country and the US continue to be, well, let’s just say uneven.

Chinese apartment rental platform Danke Apartment has also filed for an initial public offering in the US, having raised $875m from investors including Ant Financial, UCommune and Bertelsmann Asia Investments. The company was valued at more than $2bn as of a $500m round led by Ant Financial in March, and has set a placeholder amount of $100m for the IPO. Expect that to rise substantially.

And another one: I-Mab Biopharma has also opted for the US, having filed for a $100m initial public offering on the Nasdaq Global Market. The company is developing several drug candidates to treat cancer or autoimmune diseases and its largest investors include Tasly and Genexine.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

29 July 2019 – SoftBank Secures $108bn for Second Vision Fund

Big ones

SoftBank confirmed on Friday morning that it has secured a total of $108bn for its second Vision Fund, providing $38bn of the cash itself. That’s slightly less than the $50bn rumoured earlier in the week, but still a significant increase on the $28bn the telco giant put into the first fund.

Short-term accommodation platform developer Oyo has raised a total of about $1.6bn from investors including SoftBank, Airbnb, Didi Chuxing, Grab, Hero Enterprise and China Lodging Group, and two of its other investors – Sequoia Capital and Lightspeed Venture Partners – are reportedly divesting about $1.5bn of shares through a buyback scheme led by Oyo CEO Ritesh Agarwa.

Ke.com, a spinoff of online real estate portal Lianjia that utilises technologies such as virtual reality and 3D modelling, has secured nearly $1.2bn in a series D round led by an $800m investment by Tencent.

And in an interesting cross-over deal, X-Vax Technology, a US-based herpes vaccine developer based on research at Albert Einstein College of Medicine, received $56m in a series A round featuring Johnson & Johnson Innovation – JJDC, the corporate venturing vehicle for medical products group Johnson & Johnson.

Deals

Microsoft is making its own big capital outlay, investing $1bn in artificial intelligence research organisation OpenAI. Formed as an entity that would seek to steer AI research away from malevolent or even dystopian uses toward more universally beneficial areas, OpenAI is run by a non-profit organisation and had not revealed details of any prior financing.

Toyota has invested $600m in Didi Chuxing at a reported $62bn valuation, as part of a joint venture agreement that will involve the companies partnering to provide additional services to the latter’s drivers. Didi Chuxing isn’t the only ride hailing service to get funding from Toyota either.

Hellobike has entered discussions to raise $400m in a round led by existing corporate investor Ant Financial. The bicycle sharing service will reportedly be valued at about $5bn and the news comes three months after backers including WM Motor, Fosun and Bertelsmann Asia Investments exited the company.

Digital brokerage RobinHood has received $323m in a series E round that valued it at $7.6bn. The round was led by DST Global and it took the total raised by the company, which counts Alphabet and Roc Nation as investors, to more than $860m.

Vietnamese payment technology and services provider VNPay is reportedly in talks to raise $300m at a $1bn+ valuation, with SoftBank Vision Fund in line to provide up to $200m.

Bicycle and electric scooter rental service Lime raised $310m in February, and now its key rival, Bird, is reportedly seeking up to $300m of series D funding at a $2.5bn valuation.

Gusto is proving there are still some big enterprise software exits to come, the human resources platform developer having raised $200m in a Fidelity-led round at a $3.8bn valuation.

Funds

Financial services firm Industrial Bank and insurance group Ping An’s Real Estate Investment unit have backed the inaugural healthcare-focused fund raised by China-based venture capital firm Shenzhen Capital.

VR hardware and software developer Moiin is putting together a $100m fund that will back startups working on small-scale tech that would boost VR gaming.

On GUV, life sciences incubator Pennsylvania Biotechnology Center of Bucks County is to establish a $50m fund that will take equity in resident businesses including those exploiting academic research.

Exits

Livongo Health has had one of the year’s more successful IPOs, securing more than $355m and floating well above its range while adding 2 million shares to the offering.

Healthcare data analytics platform Health Catalyst operates in a broadly similar area to Livongo and guess what – it’s also had a bumper IPO. It too increased the number of shares in the offering and priced them above its range to raise $182m.

On GUV, Jukedeck, a UK-based digital music production software developer spun out of University of Cambridge, has been acquired by  TikTok, a video-based social media platform owned by internet technology producer Bytedance, for an undisclosed sum. Jukedeck had developed an online software platform that exploited artificial intelligence to automatically compose original, royalty-free music based on certain parameters, such as genre and tempo, set by the user.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

03 June 2019 – Possible PhonePe Spinout from Flipkart in $1bn Deal

Big Ones

Right now it feels like we’re gearing up for another period of significant funding, if the rumour mill is anything to go by. Mobile payment platform PhonePe was acquired by Flipkart in 2016, the year after it was founded, but could now be spun back out in a round that could reportedly reach $1bn.

Life insurance firm Northwestern Mutual launched its $50m Northwestern Mutual Future Ventures unit in early 2017 and has since built up one of the more notable CVC portfolios for an insurer, adding the likes of Chime, Ojo Labs and Ladder to existing investments such as Betterment.

Investment firm Insight Partners was already an investor in threat intelligence provider Recorded Future but has taken a step further, acquiring a controlling stake at a valuation of $780m.

Thrive Earlier Detection, a US-based developer of a blood test for cancer, was spun out of Johns Hopkins University on Thursday with $110m in series A funding from investors led by venture capital firm Third Rock Ventures. BlueCross BlueShield Venture Partners, the corporate venturing subsidiary of health insurer Blue Cross and Blue Shield Association, participated in the round, as did molecular diagnostics company Exact Sciences.

UK-based investment firm Woodford Investment Management has sold its entire shareholding in Oxford Sciences Innovation (OSI), the university venture fund of University of Oxford. The stake, worth £55m ($69.6m), has seemingly been sold to family offices and international investors.

Morningstar downgraded the Equity Income fund from bronze to neutral last week after its value shrunk from £10.2bn in 2017 to just £4.4bn, while St James’ Place, the largest wealth manager in the UK, put the firm on its watchlist after a prolonged poor performance.

Deals

SpaceX has added $1.02bn in new funding according to two separate securities filings, though it hasn’t disclosed details of the investors.

Toyota already has Uber and Grab in its portfolio but it is said to be mulling over an investment of about $550m in fellow ride hailing service Didi Chuxing.

SoFi has expanded from its core business of online lending and student loan refinancing to take in services such as online investments and digital banking, and it has also raised a further $500m in funding, this time in a round led by Qatar Investment Authority.

Lenskart has been one of Asia’s most successful proponents of the consumer goods business model involving an expansion from e-commerce to the offline world, and the eyewear retailer is reportedly in discussions to raise $350m from SoftBank Vision Fund at a $1.3bn valuation.

Oncology data platform developer Tempus has raised $200m in series F funding from investors including Novo at a $3.1bn valuation.

RobinHood was valued at $5.6bn back when it last raised money, early last year, but the Alphabet and Roc Nation-backed trading app developer is seeking $200m from existing investors at a reported valuation of up to $8bn.

Funds

Growth equity vehicle EV Growth was formed by East Ventures and corporate VC units SMDV and YJ Capital early last year with a $150m target for its first fund. It’s ended up overshooting that by a food amount, closing the fund at $200m having received commitments from limited partners including SoftBank. The fund has invested in 12 portfolio companies to date.

Exits

Palo Alto Networks has agreed to pay $410m to acquire container security software developer Twistlock, which had raised $63m from investors including Dell Technologies Capital.

BridgeBio Pharma is developing drugs to treat genetic diseases including forms of cancer linked to genetic causes. It has filed for a $225m initial public offering that will follow more than $480m in venture funding from investors including AIG, though only KKR and Viking Global Investors hold stakes of 5% or more.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

14 May 2018 – China About to Finalise $47bn Semiconductor and Chip Investment Fund

Deals

Online medical booking and healthcare services portal WeDoctor has raised $500m at a $5.5bn valuation, securing the cash in a round co-led by insurer AIA, which is now the company’s life and health insurance partner, and conglomerate NWS Holdings.

Commission-free online trading platform Robinhood is on a tear, having raised $363m in a series D round that more than quadrupled its valuation to $5.6bn in just over a year, during which it added options and cryptocurrency trading features.

Hybrid cloud software provider Mesosphere has raised $125m in a series D round co-led by Koch Industries subsidiary Koch Disruptive Technologies that also featured Hewlett Packard Enterprise and the Qatar Investment Authority.

Moderna Therapeutics first formed a strategic collaboration agreement with Merck & Co two years ago, and now the RNA therapeutics developer has received $125m from Merck as part of a deal to enhance that agreement.

Intel Capital’s annual Global Summit has revealed its latest batch of portfolio companies, which received a total of $72m from the corporate, which was spread across 12 companies.

On GUV, Escient Pharmaceuticals, a US-based biotechnology spinout from Johns Hopkins University, launched last week with a $40m series A round backed by spinout-focused investment firm Osage University Partners.

Funds

Logistics firm GLP has set up a $1.6bn investment fund that will target technology-focused companies in the logistics sector.

China is about to finalise a $47bn investment fund focusing on semiconductor research and chip development.

US-based life sciences investment firm Foresite Capital has closed a $668m fund that included several unnamed university endowments among the limited partners.

On GUV, Yale University received a $15m grant from philanthropic organisation Blavatnik Family Foundation yesterday to expand the Blavatnik Fund for Innovation to $25m.

Exits

Walmart has confirmed its $16bn purchase of a 77% stake in India-based e-commerce company Flipkart, in what is the biggest M&A exit of a VC-backed company since Facebook’s $19bn purchase of WhatsApp in 2014.

Recruit has agreed to acquire employment listings and employee review platform Glassdoor for $1.2bn in cash, enabling Alphabet’s CapitalG to exit.

Huya, livestreaming platform YY’s game-themed spinoff, secured $180m on Friday in a US IPO in which it floated at the top of its range.

Meili, the Chinese fashion e-commerce platform formed by the merger of Meilishuo and Mogujie, has hired underwriters for an initial public offering in the US that is expected to raise about $500m.

Indian renewable power producer ReNew Power, which counts Japan-based utilities Tokyo Electric and Chubu Electric as well as a subsidiary of sovereign wealth fund Abu Dhabi Investment Authority as backers, has filed for an IPO in its home country that it expects will raise up to $386m.

Mobile POS technology producer iZettle announced plans to go public in its home country of Sweden, in an IPO slated to raise approximately $226m.

On GUV, Benevir Biopharm, a US-based immunotherapy developer based on research at New York University (NYU), is set to be acquired by biotechnology firm Janssen Biotech for up to $1.04bn.

Autolus, a UK-based cancer-focused biopharmaceutical spinout from University College London (UCL), filed for a $100m initial public offering on Nasdaq.

And one exit that has collapsed is StretchSense, a New Zealand-based wearable sensor manufacturer spun out from University of Auckland, which has had to let go 140 staff after e-commerce firm StartToday terminated an acquisition deal.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0